Victory Capital Management
PRME icon

Victory Capital Management’s Prime Medicine PRME Stock Holding History

Victory Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$33.3K Sell
10,903
-76
-0.7% -$252 ﹤0.01% 2461
2026
Q2 		$40.5K Buy
10,979
+162
+1% +$538 ﹤0.01% 2407
2026
Q1 		$37.6K Buy
10,817
+16
+0.1% +$61 ﹤0.01% 2340
2025
Q4 		$37.5K Buy
10,801
+611
+6% +$2.72K ﹤0.01% 2354
2025
Q3 		$56.5K Buy
+10,190
New +$41.4K ﹤0.01% 2331

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Alessandra Capital Management
Alessandra Capital Management Torrance, California $142M AUM 42.73% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Victory Capital Management's PRME Position: Q3 2026 in Review

Victory Capital Management reduced its Prime Medicine (PRME) stake by 0.69% in Q3 2026, selling an estimated $252 and leaving 10,903 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

Victory Capital Management first reported a position in PRME in Q3 2025 and has held it in 5 quarters since. The position peaked at $56.5K in Q3 2025. 79 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Victory Capital Management held 10,903 shares of Prime Medicine worth $33.3K as of Q3 2026.
  • Victory Capital Management sold 76 Prime Medicine shares in Q3 2026, an estimated $252.
  • Prime Medicine made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2461 holding.
  • Victory Capital Management first reported a position in Prime Medicine in Q3 2025 and has held it in 5 quarters since.
  • Victory Capital Management's Prime Medicine position peaked at $56.5K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.